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Engineering commensal organisms for challenging
applications, such as modulating the gut ecosystem,
is hampered by the lack of genetic parts. Here, we
describe promoters, ribosome-binding sites, and
inducible systemsforuse in thecommensalbacterium
Bacteroides thetaiotaomicron, a prevalent and stable
resident of the human gut. We achieve up to 10,000-
fold range in constitutive gene expression and 100-
fold regulation of gene expression with inducible pro-
moters and use these parts to record DNA-encoded
memory in the genome. We use CRISPR interference
(CRISPRi) for regulated knockdown of recombinant
and endogenous gene expression to alter the meta-
bolic capacity of B. thetaiotaomicron and its resis-
tance to antimicrobial peptides. Finally, we show
that inducible CRISPRi and recombinase systems
can function in B. thetaiotaomicron colonizing the
mouse gut. These results provide a blueprint for engi-
neering new chassis and a resource to engineer Bac-
teroides for surveillance of or therapeutic delivery to
the gut microbiome.
INTRODUCTION
Bacteroides species are prominent Gram-negative anaerobic
symbionts of the mammalian gut microbiome (Human Micro-
biome Project Consortium, 2012), comprising 30% of culturable
anaerobes in the human gastrointestinal tract (Salyers, 1984). Of
the Bacteroides genus, Bacteroides thetaiotaomicron is both
prevalent (present in 46% of humans) (Human Microbiome Proj-
ect Consortium, 2012) and abundant (up to 1010 per g stool)
(Salyers, 1984), making it a promising organism for both under-
standing and manipulating the gut environment. Stable and
robust colonization of the densely populated gut environment
is facilitated by the metabolic diversity of Bacteroides (Lee
et al., 2013). Specifically, B. thetaiotaomicron and its relatives
are equipped with an extensive repertoire of saccharolytic
enzymes and serve as primary fermenters of host-, diet-, or
microbially-derived polysaccharides (Martens et al., 2008).62 Cell Systems 1, 62–71, July 29, 2015 ª2015 Elsevier Inc.Moreover, members of Bacteroidetes, the phylum to which
B. thetaiotaomicron belongs, were among the most stable com-
ponents of the human gut microbiota in a 5-year longitudinal
study (Faith et al., 2013), making them useful candidates for
long-term cellular diagnostics and therapeutics in the gastroin-
testinal tract.
To date, multiple microorganisms have served as chassis for
engineered microbial therapies of human disease. Recombi-
nant, attenuated strains of Salmonella spp. (Nemunaitis et al.,
2003) and Listeria monocytogenes (Rothman and Paterson,
2013) were used as vectors for anti-cancer therapies in several
human trials. Lactococcus lactis has been implemented as a
chassis for the production of therapeutic molecules targeting
human inflammatory diseases (Steidler et al., 2003). In mouse
models, strains of Escherichia coli were engineered to produce
molecules that reduce food intake and obesity (Chen et al.,
2014). However, compared to E. coli (Kotula et al., 2014) and
L. lactis (Steidler et al., 2003), which undergo depletion or clear-
ance within days of administration, Bacteroides populations
exhibit low variation in abundance and long-term colonization
(Lee et al., 2013).
Genetic parts and circuits enable control over the level and
timing of expression of multi-gene traits in response to environ-
mental conditions. Recently, new techniques in DNA construc-
tion and high-throughput screening have led to a resurgence in
part design, including a revisiting of the organization of the
‘‘expression cassette’’ (Leavitt and Alper, 2015; Nielsen et al.,
2013). For model organisms, large libraries and computational
models of promoters, ribosome binding sites, and terminators
enable fine control of multi-gene systems (Nielsen et al., 2013).
Insulators have been designed for integration between parts to
ensure that parts can be swapped without impacting function
(Brophy and Voigt, 2014; Geyer, 1997; Mutalik et al., 2013). How-
ever, a challenge with engineering non-model organisms has
been a lack of these tools, which limits the sophistication of
the systems that can be constructed (Mutalik et al., 2013).
Few genetic parts and inducible systems are available for
B. thetaiotaomicron and its relatives. Previous efforts have co-
opted natural glycan-sensing systems (Hamady et al., 2008) or
the classic E. coli lac operon (Parker and Smith, 2012) for
inducible genetic systems, yielding systems that span a 10- to
50-fold range of expression. Replicative plasmids (Smith et al.,
1992) and integrative transposons (Wang et al., 2000)
have been built for the introduction of heterologous genes.
However, unlike most other prokaryotes, the uniquemajor sigma
factor in Bacteroides binds to a 33/7 consensus sequence
(TTTG/TAnnTTTG) (Bayley et al., 2000; Vingadassalom et al.,
2005). Moreover, the strength of translation initiation is poorly
correlated with the level of ribosome binding site (RBS) comple-
mentarity to the 16S rRNA of the host organism (Wegmann et al.,
2013). Compared to the E. coliRBS,BacteroidesRBS strength is
more sensitive to secondary structures (Accetto and Avgustin,
2011), depleted in GC content (Wegmann et al., 2013), and pre-
dicted to rely more heavily on interactions with ribosomal protein
S1. These unique promoter and RBS architectures in Bacter-
oides preclude the direct incorporation of genetic systems
developed in other organisms (Smith et al., 1992). A lack of
genetic part libraries hinders the introduction of multi-gene path-
ways, such as those that could produce ametabolic product de-
signed to treat disease.
Multiple cellular states are naturally maintained within Bacter-
oides populations via reversible recombinases that vary ex-
pression of cell-surface polysaccharides (Coyne et al., 2003).
Recombinases have been harnessed to build counters and inte-
gratedmemory-and-logic devices (Bonnet et al., 2013; Friedland
et al., 2009; Siuti et al., 2013; Yang et al., 2014). By connecting
these switches to environmental sensors, cellular memory can
be used to infer exposure to a particular set of conditions. This
is useful if direct readout of a reporter from a microenvironment
is not possible. For example, an engineered toggle switch
enabled E. coli to record exposure to antibiotics in the mouse
gut (Kotula et al., 2014). In addition to toggle switches, memory
has recently been achieved using dynamic genome editing (Far-
zadfard and Lu, 2014).
CRISPR-Cas9 technologies have revolutionized genome edit-
ing because their ease of reprogramming to target user-defined
DNA sequences with a single guide RNA (sgRNA) (Mali et al.,
2013). CRISPR interference (CRISPRi) employs a catalytically
inactive version of the endonuclease Cas9 (dCas9) to regulate
gene expression at target DNA sequences by blocking transcrip-
tion by RNA polymerase (Qi et al., 2013). The specificity of dCas9
repression is governed by sequence homology and is indepen-
dent from host machinery (Mali et al., 2013). This has enabled
implementation of CRISPRi in both bacterial and eukaryotic
systems (Qi et al., 2013), permitting both the construction of syn-
thetic gene circuits as well as the study of natural biological net-
works (Nielsen and Voigt, 2014).
Here, we expand the set of genetic tools necessary to precisely
and robustly engineer B. thetaiotaomicron for microbiome appli-
cations. We report a library of biological parts, comprised of
constitutive promoters, inducible promoters, and RBSs that
each span output-dynamic ranges of several orders ofmagnitude
(Figure 1A). Constitutive promoters and RBSswere used to char-
acterize the input expression levels required to generate recom-
binase-based DNA-encoded memory in B. thetaiotaomicron.
Externally switchable DNA-based memory devices were then
constructed by integrating inducible promoters with recombi-
nases. Additionally, inducible promoters were used to control
CRISPRi-based regulation of synthetic and endogenous genes.
Finally, we validated the function of these tools in bacteria that
have colonized the gut of mice. This includes circuits that
respond to stimuli in vivo and either record exposure by altering
gene expression or permanently modifying the genome. Thesedevices demonstrate that B. thetaiotaomicron can be used as a
platform for predictable gene expression and circuit design for
microbiome engineering.
RESULTS
Landing Pads for Genetic Part and Device
Characterization
All genetic parts in this study were characterized using the inte-
gration vector pNBU2 to ensure genetic stability of the con-
structs (Figure 1B). The pNBU2 plasmid encodes the intN2
tyrosine integrase, which mediates sequence-specific recombi-
nation between the attN site of pNBU2 and one of two attBT sites
located in the 30 ends of the two tRNASer genes, BT_t70 and
BT_t71, on the B. thetaiotaomicron chromosome (Wang et al.,
2000). Insertion of the pNBU2 plasmid inactivates the tRNASer
gene, and simultaneous insertion into both BT_t70 and BT_t71,
is unlikely due to the essentiality of tRNASer.
Expression Control through Promoter and RBS Design
To expand the range of constitutive gene expression that
can be implemented in Bacteroides, we constructed and
characterized promoter-RBS combinations using the NanoLuc
luciferase as a reporter (Figures 1B and 1C). Four promoter
variants were constructed based on the constitutive pro-
moter for the B. thetaiotaomicron housekeeping sigma factor
BT1311 (PBT1311) (Vingadassalom et al., 2005). Specifically, a
26-bp sequence was substituted or inserted into PBT1311 in re-
gions composing and surrounding the 33 and 7 promoter
sequences (Experimental Procedures; Figure S1), regions
known to be important for B. thetaiotaomicron promoter activ-
ity (Bayley et al., 2000). With NanoLuc as a reporter, the PAM
promoters spanned a 20-fold range of expression and had
decreased expression levels relative to the PBT1311 parent pro-
moter. For comparison to prior work, we also measured the
activities of the previously reported promoter-RBS pairs, PcfxA,
PcfiA, P1, and PcepA (Goto et al., 2013; Parker and Smith, 1993;
Rogers et al., 1994; Wegmann et al., 2013) (Figure 1D).
The PAM promoters were then combined with RBSs of varying
strength to increase the range of expression levels. Previously
characterized RBSs GH022, GH023, and GH078 (Wegmann
et al., 2013) have an expression range of less than one order of
magnitude (Figure 1D). We selected a ribosomal protein RBS
(rpiL*) and constructed aweakRBS (RC500) to increase the range
of our available RBSs (Figure 1D; Experimental Procedures). This
RBS library spanned a >102-fold range when paired with each
PAM-derived promoter. When combined, these PAM promoters
and RBSs could achieve expression levels over a 104-fold range.
To identify a set of RBSs for fine-tuning gene expression in
B. thetaiotaomicron, we generated three randomized rpiL* RBS
libraries targeting the most conserved positions of the Bacter-
oides ribosomal protein RBSs (Wegmann et al., 2013). For
each library, we targeted three nucleotides in and around the
rpiL* RBS Shine Delgarno sequence. These positions are within
or near the RBS region predicted to interact with the ribosomal
S1 protein (nt -21 to -11 relative to the start codon of NanoLuc,
Figure 1C) (Boni et al., 1991). We achieved 67%–80% coverage
of the 64 potential members in each library, resulting in 142 RBS
sequences (Figure 1E; Table S1). These RBSs were screenedCell Systems 1, 62–71, July 29, 2015 ª2015 Elsevier Inc. 63
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Figure 1. Genetic Parts to Control Expression in B. thetaiotaomicron
(A) The ranges of gene expression are shown for the different gene regulation systems developed in thismanuscript. AG, arabinogalactan; CS, chondroitin sulfate;
IPTG, isopropyl beta-D-1-thiogalactopyranoside; Rha, rhamnose; dCas9, catalytically inactive Cas9 endonuclease
(B) Tyrosine integrase IntN2 catalyzes stable integration of pNBU2-based expression constructs into one of two attBT2 sites in the B. thetaiotaomicron genome
(Wang et al., 2000). The two attBT2 sites (attBT2-1 at nt 6,217,227 and attBT2-2 at nt 6,138,320) are in the 30 ends of tRNASer genes (BT_t71 and BT_t70,
respectively). ApR, ampicillin resistance cassette; ErmR, erythromycin resistance cassette; RP4, origin of transfer; R6K, origin of replication; NanoLuc, luciferase
(C) Constitutive promoters and ribosome binding sites for the construction of gene expression libraries. The putative -33 and -7 regions of the PBT1311 promoter,
the Shine-Delgarno sequence, and the start codon are indicated by black boxes. Numbers below the black boxes represent nucleotide locations relative the
PBT1311 transcription start site. The 26 bp sequence introduced in the PAM promoters is shown as blue boxes (see also Figure S1). Numbers at the edges of the
blue boxes indicate the PBT1311 nucleotides replaced or the insertion site within the promoter. The location of residues randomized in the rpiL* RBS library are
indicated with red arrows (for library A: nt -14, -13, -12; for library B: nt -21, -18, -15; and for library C: nt -17, -16, -11; nt numbering is relative to the translation start
site).
(D) Activity was measured for a set of constitutive promoters and their cognate RBSs. For PAM1, PAM2, PAM3, PAM4, the BT1311 RBS was used. Furthermore,
PBT1311, PAM1, PAM2, PAM3, and PAM4 were combined with RBSs of varying strengths. Gene expression was measured using a luciferase reporter (NanoLuc) and
reported as relative light units/colony forming unit (RLU/CFU).
(E) Three large RBS libraries were constructed and combined with promoter PBT1311. For reference, the parent rpiL* RBS is indicated with a red arrow. The
sequences of the RBSs are provided in Table S1. For (D) and (E), error bars represent the SD of three independent biological replicates made on separate days.
(F) The strength of each RBS was compared to the predicted free energy of folding for the mRNA (DGfold).
(G) A consensus strong RBS and weak RBS were generated for the rpiL* RBS library using frequency logos that included the 11 strongest and 11 weakest RBSs
(residue locations are stated relative to the translation start site). Frequency logos were constructed by comparing the frequency of each nucleotide at each
position in that group with the frequency of that nucleotide in that position in the full library. Position -20 and -19 were not randomized and are not shown in the
frequency logos.
See also Tables S1 and S2.and sequenced and a set of 8 was identified that span 103-fold
expression range in approximately even increments (Table S2).
We observed only a weak positive correlation between the
minimum free energy of RBS folding (Experimental Procedures)
and expression of the NanoLuc reporter (r2 = 0.19) in the rpiL* li-
brary (Figure 1F). To visualize the impact of GC content on RBS
strength within this library, we generated frequency logos for
each nucleotide targeted in the library. The strongest RBSs
were GC-depleted relative to the overall library and the weakest64 Cell Systems 1, 62–71, July 29, 2015 ª2015 Elsevier Inc.RBSs (Figure 1G). Our RBS libraries highlight the distinct AT
enrichment of strong Bacteroides RBSs compared to other bac-
terial species, which results in part failure when constructs are
transferred into Bacteroides from other species (Wegmann
et al., 2013).
Genetic Sensors and Inducible Systems
To create inducible systems for use in B. thetaiotaomicron,
we adapted parts from the large repertoire of systems that
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Figure 2. Design and Characterization of Genetic Sensors
(A–D) Response curves for NanoLuc under the regulated control of the
rhamnose (Rha)-inducible promoters (A), chondroitin sulfate (ChS)-inducible
promoters (B), arabinogalactan (AG)-inducible promoters (C), or IPTG-induc-
ible promoters (D). LacO1 operator sites were inserted in various regions (O1,
O2, O3) of the PcfxA promoter (see also Figure S2). For (D), squares indicate
PLacO23 and circles indicate PLacO13. Inducer concentrations were applied as
follows: 3-fold serial dilutions starting at 10 mM Rha (A); 3-fold serial dilutions
starting at 0.4% for ChS (B) and AG (C); and 4-fold serial dilutions starting at
500 mM for IPTG (D). The leftmost data point in each plot represents the
background luminescence in the absence of inducer. Response curves were
fit to a Hill function (solid lines).
(E) Orthogonality matrix of sugar-inducible genetic systems incubated with
10mM rhamnose (Rha), 0.2% chondroitin sulfate (ChS), 0.2% arabinogalactan
(AG), or 100 mM IPTG compared to no inducer. Error bars represent the SD of
three biological replicates made on different days.govern carbohydrate utilization (Martens et al., 2008). In
B. thetaiotaomicron, rhamnose metabolism is mediated by the
transcriptional activator RhaR, which activates transcription at
the PBT3763 promoter (Patel et al., 2008). To assay the function-
ality of PBT3763 as an inducible system, we cloned 250 bp of
the promoter-RBS region upstream of the start codon of
BT3763 into the pNBU2 expression vector to drive expression
of NanoLuc. Gene expression was conditional on the concentra-
tion of rhamnose and demonstrated a response curve with an
output dynamic range of 104-fold (Figure 2A). Fitting the
response curve to a Hill function revealed a threshold K of
0.3 mM and a Hill coefficient n = 1.4.
Two-component systems are signal-transduction mecha-
nisms widespread in bacteria for sensing external stimuli. Bac-
teroides sp. possess a unique variant of these systems, called
hybrid two-component systems, that incorporate both the
sensor histidine kinase and response regulator of classical
two-component systems into a single polypeptide chain (Son-
nenburg et al., 2006). Putative hybrid two-component systems,
BT3334 and BT0267, were identified in transcriptomic studies
to control expression of the chondroitin sulfate (ChS)-inducible
PBT3324 promoter and arabinogalactan (AG)-inducible PBT0268
promoter, respectively (Martens et al., 2008, 2011). Chondroitin
sulfate induction of PBT3324 and arabinogalactan induction of
PBT0268 led to a 60-fold and 29-fold regulation of output gene
expression, respectively (Figures 2B and 2C).
Next,wedevelopedan isopropylb-D-1-thiogalactopyranoside
(IPTG)-inducible system based on the E. coli LacI system. Our
design expands upon on a previously developed IPTG-inducible
system in Bacteroides (Parker and Smith, 2012) by investigating
the position effects of operator sites on gene expression. Pairs
of LacO1 operator sites were inserted in the strong PcfxA pro-
moter in three locations (Figures2 andS2), and the LacI repressor
was expressed from the BT1311 promoter. Compared to the
unmodified PcfxA promoter, the addition of synthetic operator
sites diminished the maximum expression of NanoLuc (Fig-
ure S2). This strategy produced two IPTG-inducible promoters
that with thresholds at K = 86 mM (PLacO13) and K= 6 mM (PLacO23).
The induction of these systems elicited an 8- and 22-fold change
in gene expression, respectively (Figure 2D).
As the orthogonality of genetic parts is crucial for their simulta-
neous use, we tested the degree of cross-talk between each
inducible system by incubating each engineered strain with the
full set of carbohydrate inducers. The inducers themselves bear
little structural similarity: rhamnose, a methyl-pentose sugar;
ChS, a sulfated glycosaminoglycan composed of chains of ace-
tylgalactosamine and glucuronic acid residues; AG, a polysac-
charide composed of arabinose and galactose units; and IPTG,
a molecular mimic of allolactose. Functionally, each inducible
system was highly orthogonal to each other, with no cross-reac-
tivity observed with any of the combinations (Figure 2E).
Synthetic Genetic Memory
To equip B. thetaiotaomicron with permanent genetic memory,
we used serine integrases, which catalyze unidirectional inver-
sion of the DNA sequence between two recognition sequences
(Figure 3A) (Grindley et al., 2006). Recently, 11 orthogonal inte-
grases and their recognition sequences were characterized in
E. coli (Yang et al., 2014), and a DNA ‘‘memory array’’ composedCell Systems 1, 62–71, July 29, 2015 ª2015 Elsevier Inc. 65
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Figure 3. Synthetic Genetic Memory
(A) Integrases mediate recombination of DNA between integrase binding sites
(attB/attP), resulting in the inversion of the intervening spacers.
(B) Schematic of the location of the promoter-RBS-integrase system and the
memory array cassettes in the B. thetaiotaomicron chromosome.
(C) Integrase-mediated DNA inversion at each integrase target sequence in the
memory array cassette is detected by PCR. Primer pairs (arrows) anneal to the
interface of the integrase recognition sites and to the spacer region between
recognition sites. PCR amplification occurs only after an inversion event (solid
lines below the primer arrows indicate expected amplicons).
(D) Representative PCR products are shown after recombination with in-
tegrases Int7, Int8, Int9, or Int12. – indicates no integrase, + indicates the
integrase is present. PAM4-rpiL* was used to control expression of each in-
tegrase (see also Figure S3.)
(E) Schematic of the rhamnose-inducible recombinase circuit. Transcriptional
activator RhaR, produced from the endogenous locus, is activated in the
presence of rhamnose causing expression of Int12 from PBT3763. Int12 medi-
ates recombination between the Int12 attB and attP recognition sequences.
(F) Response curve of Int12memory circuit. Int12 was placed under the control
of a subset of PBT3763-rpiL*C51. Inducer concentrations were 9-fold serial
66 Cell Systems 1, 62–71, July 29, 2015 ª2015 Elsevier Inc.of a linear concatenation of integrase recognition sequences
was used to record the expression of one or multiple integrases
in response to a stimulus.
We identified serine integrases that function in
B. thetaiotaomicron by cloning the integrases into a strong consti-
tutive expression vectors (PAM4-rpiL*, 1.2 3 10
2 RLU/CFU). To
provideastable, single-copy recordofDNA inversion,we incorpo-
rated the DNAmemory array containing the integrase recognition
sequences into the B. thetaiotaomicron chromosome (Figures 3B
and 3C; Experimental Procedures). Integrase expression vectors
wereconjugated into theB. thetaiotaomicronmemoryarray strain.
GenomicDNAwas isolated from transconjugantsandanalyzedby
PCR to detect flipping. Four integrases, Int7, Int8, Int9, and Int12,
each catalyzed recombination at the respective recognition
sequence in the memory array (Figure 3D), and DNA inversion
was not detected in the absence of an integrase (Figure S3A).
To create an inducible memory switch, we cloned Int12 under
the control of the rhamnose-inducible promoter with the
rpiL*RBS variant C51 (Figures 1E and 3E; Table S1). The Int12 re-
combinase switch responded to increasing concentrations of
rhamnose (Figure 3F) within 2 hr (Figure 3G), with no background
detected in the absence of inducer. Notably, expression of Int12
did not impact growth of B. thetaiotaomicron, even when maxi-
mally expressed (Figure S3B).
CRISPRi-Mediated Gene Knockdown
CRISPRi can provide a facile toolbox for constructing syn-
thetic gene circuits and modulating endogenous genes in
B. thetaiotaomicron. To demonstrate the use of CRISPRi-medi-
ated gene knockdown for synthetic constructs, production of
dCas9 was regulated by the IPTG-inducible PLacO23 system.
sgRNAs were constitutively expressed from the P1 promoter and
were designed to target the coding sequence of NanoLuc (NL1-
4) or the PcfiA promoter (PR1-2) (Figure 4A). A nonsense sgRNA
(NS) with no sequence identity to either PcfiA or NanoLuc was
used as a negative control. All specifically targeted sgRNAs
repressed the expression of NanoLuc (Figure 4B) by 20- to
45-fold with IPTG induction of dCas9 expression (Figure 4C),
thus implementing genetic NOT gates in B. thetaiotaomicron.
The IPTG-to-NanoLuc response function of sgRNAs targeting
the coding sequenceorpromoter exhibitedsimilarHill coefficients
and lower dissociation constants to the IPTG-to-NanoLuc
transfer function of the PLacO23 promoter on its own (n = 1.1–1.4;
K = 0.6–1.4 mM IPTG).dilutions starting at 10 mM rhamnose. The leftmost data point represents the
recombination in the absence of inducer. Cells were grown 8 hr at 37C before
harvesting cells and isolating DNA. Absolute quantities of flipped and un-
flipped memory array in genomic DNA were determined by qPCR using
standard curves (Experimental Procedures). The recombination ratio is ex-
pressed as the ratio of cells containing a flipped memory array (Flipped)
divided by the sum total of cells containing a flipped or unflipped array (Total).
Data were fit with a Hill function to guide the eye (see also Figure S3).
(G) Int12-mediated recombination versus time. Cells were induced with 10mM
rhamnose at t = 0. Absolute quantities of flipped and unflippedmemory array in
genomic DNA were determined by qPCR using standard curves (Experimental
Procedures). Recombination ratios were determined as in (F). Data were fit
with a sigmoidal dose-response function to guide the eye. For (F) and (G), error
bars represent the SD of three biological replicates made on different days.
See also Figure S3.
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Figure 4. CRISPRi-Mediated Repression of Recombinant and
Endogenous Genes
(A) Schematic of dCas9-based repression of NanoLuc. Addition of IPTG in-
duces expression of dCas9, which complexes with constitutively expressed
sgRNA targeting the coding sequence of NanoLuc (NL1-4) or the PcfiA pro-
moter (PR1-2). The plasmid backbone separates the NanoLuc cassette and
the IPTG-inducible CRISPRi system.
(B) Response curves of dCas9-mediated targeting the coding sequence of
NanoLuc (NL1-4), the promoter (PR1-2) or a nonsense sequence (NS). Four-
fold serial dilutions of IPTG starting at 500 mM or no inducer were added to
cultures. Response curves were fit to a Hill function (solid lines).
(C) Fold repression elicited by various gRNAs in the presence (500 mM) of
inducer. Bars are colored to correspond to (B).
(D) Genomic location of endogenous genes targeted using CRISPRi.
(E) Minimum inhibitory concentrations (MICs) of polymyxin B for cells with
CRISPRi targeted against BT1854 (dCas9BT1854) compared with wild-type
(WT) cells or non-specific control cells (dCas9NS). Reported values are
the mode of three independent biological replicates made on three separate
days.
(F) CRISPRi was targeted against BT1754 (dCas9BT1754). Growth curves of
wild-type (WT) (black), dCas9BT1754 (pink), or dCas9NS (gray) cells in minimal
media supplemented with 0.5% glucose (MM-Glc) or 0.5% fructose (MM-Fru)
in the presence (full line) or absence (dotted line) of 100 mM IPTG. Error bars
represent the SD of three biological replicates made on different days.To demonstrate the programmable knockdown of endoge-
nous genes in B. thetaiotaomicron, we designed sgRNAs to
target mechanisms implicated in the resilience of Bacteroides
in the human microbiota. In B. thetaiotaomicron, LpxF, the
gene product of BT1854, is required for resistance to inflamma-
tion-associated cationic antimicrobial peptides, such as poly-
myxin B (Cullen et al., 2015). Using the minimum inhibitory
concentration (MIC) of polymyxin B as a phenotypic readout,
we designed an sgRNA to specifically suppress BT1854 expres-
sion. In cells containing the sgRNA targeted against BT1854
(dCas9BT1854), the induction of dCas9 with led to sensitization
of the cells to polymyxin B treatment (8- to 16-fold decrease in
MIC), while wild-type B. thetaiotaomicron and strains containing
dCas9NS demonstrated high levels of polymyxin B resistance in
the presence or absence of dCas9 induction with IPTG (Figures
4D and 4E).
Next, we explored dCas9-mediated repression of carbohy-
drate-utilization pathways in B. thetaiotaomicron, which are im-
portant for the bacterium’s ability to successfully and persistently
colonize the mammalian gut. The hybrid two-component sensor
BT1754 regulates the BT1757-1763/BT1765 fructose-containing
polysaccharide utilization locus, and BT1754 is essential for
growth on fructose as the sole carbon source (Sonnenburg
et al., 2010). We designed a specific sgRNA to repress BT1754
and integrated this system into the B. thetaiotaomicron genome
along with an IPTG-inducible dCas9 cassette (dCas9BT1754) (Fig-
ures4Dand4F). InductionofdCas9BT1754didnot affect thegrowth
rateofcells onminimalmedia (MM)-glucosecompared toWTcells
and dCas9NS. The generation time G = (log102 3 t)/log10(B/B0)
z1 hr (where t is the time interval, and B0 and B are the initial
and final concentrations of bacteria, respectively), indicating that
neither dCas9 induction nor repression of BT1754 impacts growth
on glucose media (Figure 4F). However, induction of dCas9BT1754
drastically decreased the growth rate of the cells in MM-fructose
(G = 4.7 hr) while the growth of WT and dCas9NS cells in MM-
fructose remained similar (G = 1 hr) to growth inMM-glucose (Fig-
ure 4F). Thus, inducible dCas9-mediated repression of endoge-
nous genes can alter both the resistance and metabolic profiles
of B. thetaiotaomicron.
Function of Genetic Parts in B. thetaiotaomicron
Colonizing the Mouse Gut
We next investigated whether the function of our
B. thetaiotaomicron genetic parts and modules can be main-
tained in the context of a complex microbiota. As wild-type
strains ofBacteroides spp. are unable to stably colonize conven-
tional specific-pathogen-free (SPF) mice (Lee et al., 2013; Cullen
et al., 2015), we employed an antibiotic regimen that promotes
B. thetaiotaomicron colonization without sterilizing the gut
microbiota (Figure 5A) (Bloom et al., 2011; Lee et al., 2013). A
10-day treatment of animals with ciprofloxacin and metronida-
zole prior to bacterial inoculation was sufficient to maintain
stable and high levels of colonization for the duration of the ex-
periments (up to 12 days tested) (Figure S4).
Using this model, we tested the functionality of our inducible
systems, CRISPRi, and integrases in vivo. First, SPF mice were
colonized with the strain containing the arabinogalactan-induc-
iblePBT0268promoter-drivingexpressionofNanoLuc (FigureS4A).
Within a day of addition of arabinogalactan to the drinking waterCell Systems 1, 62–71, July 29, 2015 ª2015 Elsevier Inc. 67
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Figure 5. In Vivo Function of Genetic Parts within B. thetaiotaomicron Colonizing the Mouse Gut
(A) Experimental timeline. Specific-pathogen-free (SPF) Swiss Webster mice were treated for 10 days with ciprofloxacin and metronidazole and gavaged with
B. thetaiotaomicron 2 days after cessation of treatment. Bacterial gavage was administered on Day 0 (B–D).
(B and C) Luciferase activity in fecal pellets of mice inoculated with strains possessing the arabinogalactan (AG)-inducible PBT0268 (B) or IPTG-inducible CRISPRi
dCas9NL3 (C) systems. Mice were provided drinking water supplemented with 5% arabinogalactan (B) (solid line), or 25 mM IPTG (C) (solid line) for 2 days after
stool collection on Day 2 (gray box), or were maintained on normal drinking water throughout the entire experiment (dashed lines). Inducer water was removed on
Day 4 after stool collection. Luminescence values were normalized to cell density as determined by qPCR using NanoLuc-specific primers.
(D) SPF mice were colonized with B. thetaiotaomicron containing the rhamnose-inducible integrase construct PBT3763-rpiL*C51-Int12. All mice were exposed to
0.3% rhamnose (w/w) in the plant-based chow. In addition, half of themice had their drinkingwater supplementedwith 500mM rhamnose after stool collection on
Day 1 (‘‘Chow +Rha,’’ solid line) while the other half of themiceweremaintained on normal drinkingwater throughout the entire experiment (‘‘Chow,’’ dashed line).
Mice receiving rhamnose-supplemented water on Days 1 and 2 (gray box) were returned to normal water on Day 3 after stool collection. Recombination ratios
were determined for fecal DNA as described in Figure 3F. For day 3 ‘‘Chow’’ samples, n = 3. For all other days, n = 6 for both treatment groups. See also Figure S4.
For (B)–(D), individual points represent independent biological replicates and the line represents the mean of the group. *p < 0.05, **p < 0.01.of the mice, luciferase activity in fecal pellets increased 75-fold
(Figure 5B). Following removal of inducer from the drinking water,
luciferaseactivity in the fecalpellets ofmice fed inducer rapidly re-
turned to baseline, demonstrating tight temporal control of gene
expression dependent on arabinogalactan.
To investigate whether more complex genetic circuits per-
form in the context of the mouse microbiome, we evaluated
the dCas9NL3 repressor cascade, which is composed of the
CRISPRi system as well as the PLacO23 IPTG-inducible promoter,
within stably colonized B. thetaiotaomicron. Within 24 hr of add-
ing IPTG to drinking water, CRISPRi elicited an 20-fold reduc-
tion in gene expression compared to the uninduced control
(Figure 5C). The fold repression observed in vivo is similar to
that measured in vitro. Luciferase activity returned to baseline
6 days following the removal of IPTG from drinking water. More-
over, expression of dCas9 and NanoLuc did not significantly
impact in vivo fitness compared to uninduced controls (Figures
S4A and S4B).
To test the function of recombinases in vivo, we colonized
mice with a B. thetaiotaomicron strain containing the rham-
nose-inducible Int12 integrase memory switch (Figure 3E). All
mice were fed with plant-based chow that was determined to
be composed of 0.3% rhamnose (w/w). In addition, after 1 day
of colonization, the drinking water of half of themice was supple-
mented with 0.5 M rhamnose to further induce the memory
switch. Stool was collected over the course of the experiment,
and the absolute number of unflipped (wild-type) and flipped
Int12 recognition sequences was determined by qPCR (Fig-
ure 5D; Experimental Procedures). A background recombination68 Cell Systems 1, 62–71, July 29, 2015 ª2015 Elsevier Inc.rate of 11% per day was detected in mice fed on rhamnose-
containing chow but not supplemented with rhamnose in their
drinking water (Figure 5D, ‘‘Chow’’). In mice supplemented
with exogenous rhamnose (Figure 5D, ‘‘Chow + Rha’’), the
recombinase switch achieved >90% flipping in%1 day, a statis-
tically significant increase over mice not supplemented with
rhamnose in the water (p < 0.01; Figure 5D).
DISCUSSION
Here, we developed a versatile set of genetic technologies for the
manipulation of the abundant gut symbiont B. thetaiotaomicron.
Given the distinct transcriptional and translational control mecha-
nisms in B. thetaiotaomicron, we laid the foundation for circuit
design in B. thetaiotaomicron by identifying promoters and
RBSs for this organism through literature searches and library
construction. The resulting toolbox expanded upon the number
and expression range of genetic parts available for Bacteroidetes
(previous range: 102) (Accetto and Avgustin, 2011; Hamady et al.,
2008; Parker and Smith, 2012; Wegmann et al., 2013) and
achieved ranges of expression similar to those of libraries charac-
terized for other gut-associated bacteria, including E. coli (range:
104–105) (Cox et al., 2007; Kosuri et al., 2013; Salis et al., 2009)
and lactic acid bacteria (range: 103) (Jensen and Hammer,
1998; Kleerebezem et al., 1997). Using a similar approach, we
characterized four orthogonal-inducible expression systems.
This library of B. thetaiotaomicron promoters and RBSs enabled
us to import host-independent machinery, dCas9 and serine inte-
grases, to implement more complex circuits. We envision that
similar approaches, coupled with continuing advances in DNA
sequencing and synthesis technologies, will enable the rapid
and large-scale porting of genetic parts and devices from model
organisms into new chassis that can address real-world applica-
tions. Lastly, we demonstrated the functionality of these genetic
parts in the context of the mouse microbiome. Future work will
focus on scaling the complexity of genetic circuits that can be im-
plemented in commensal bacteria and pursuing long-term and
quantitative control of microbial and mammalian host biology
in vivo.
For microbiome engineering applications, the ability to pre-
ciselymodulate gene expression in commensal organisms should
enable functional studies of the microbiome, non-invasive moni-
toring of in vivo environments, and long-term targeted thera-
peutics. For example, our constitutive and inducible systems,
integrases, and CRISPRi regulators could be integrated for
higher-order computation in B. thetaiotaomicron, such as digital
logic, memory, and analog circuits. These engineered commen-
sals could be used to map the dose-dependent and temporal
effects of specific surface polysaccharides (Liu et al., 2008) or
heterologous pathways (Claesen and Fischbach, 2015) on colon-
ization and maintenance of the gut microbiota and on host
health. Higher-order combinations of inducible promoters linked
with integrases could achieve Boolean logic with embedded
cellular memory (Siuti et al., 2013), enabling surveillance of
the gut environment. Furthermore, environmental sensing with
analog circuits (Daniel et al., 2013) coupled with precision expres-
sion control of heterologous pathways in B. thetaiotaomicron
could be exploited for on-demand, localized, and rheostatic
delivery of therapeutic molecules. We have also shown that
the CRISPRi system can be used to dynamically manipulate
bacterial processes in B. thetaiotaomicron by targeting endoge-
nous genes. dCas9-mediated repression could be induced in a
commensal library ofB. thetaiotaomicron harboring distinct guide
RNAs to identify genes required for B. thetaiotaomicron mainte-
nance (Sonnenburg et al., 2010) or interspecies interactions
(Mahowald et al., 2009). With these genetic resources, we envi-
sion that B. thetaiotaomicron will be a useful platform for cellular
sensing, computation, and actuation at the host-microbe inter-
face in the gut.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Culture Conditions
B. thetaiotaomicron VPI-5482 (ATCC 29148) (GenBank: AE015928.1) was
used for all studies except for the integrase-based memory units.
B. thetaiotaomicron VPI-5482 Dtdk was used for the insertion of the memory
array and the characterization of integrases.
Genetic Parts and Plasmids
Genetic parts and plasmids used in this study are listed in Tables S3 and S4
and will be publically available and deposited in Addgene upon publication.
Single guide RNAs (sgRNA) used in this study are listed in Table S5. pNBU2
constructs were conjugated into B. thetaiotaomicron from E. coli. The DNA
memory array cassette (Yang et al., 2014) was introduced into the chromo-
some of a B. thetaiotaomicron Dtdk strain by allelic exchange (Supplemental
Experimental Procedures).
Construction of Promoter and RBS Libraries
Promoters and RBS libraries were constructed by PCR using primers with spe-
cific or degenerate sequences (Supplemental Experimental Procedures).Luciferase Assay
NanoLuc luciferase assay was performed with cell lysates or fecal suspen-
sions according to the manufacturer’s suggestions (Supplemental Experi-
mental Procedures). Luciferase activities were measured with an integration
time of 1 s at a gain setting of 100 in a BioTek Synergy H1 Hybrid Reader.
Construction and Analysis of the rpiL* RBS Library
The rpiL* RBS was mutagenized by amplifying the plasmid pAT593 (encoding
PBT1311-rpiL*-NanoLuc in a pNBU2 vector) with primer oAT617 in combination
with primer oAT614, primer oAT615, or primer oAT616 (Table S6), which were
each synthesized with degenerate nucleotides at three positions (43 = 64 po-
tential members in each library). The resulting fragments were digested with
BbsI, ligated with T4 ligase, and digested with DpnI, yielding three scarless
PBT1311-rpiL* RBS libraries.
Growth and Induction
For inducible promoter and dCas9 assays, overnight cultures were diluted
1:100 in fresh tryptone yeast extract glucose medium (TYG) supplemented
with inducer. The inducers used were IPTG (Goldman), L-rhamnose (Sigma),
chondroitin sulfate A from bovine trachea (Sigma), (+)-arabinogalactan from
larch wood (TCI), and fucose (Sigma). Cultures were grown anaerobically at
37C to an optical density (OD600) of 0.4–0.8 (5 hr) before assaying lucif-
erase activity.
In Vitro Genetic Memory Assays
To identify integrases that function inB. thetaiotaomicron, pNBU2-based plas-
mids containing PAM4-rpiL*RBS-integrase combinations were conjugated into
B. thetaiotaomicron Dtdk harboring a chromosomal copy of the memory array.
Cells were plated on BHIS+Gm+Erm to select for strains that contained the
promoter-RBS-integrase plasmids. DNA was isolated from transconjugants
were grown were assayed by PCR for inversion of spacer sequences in the
memory array cassette as described (Yang et al., 2014). Control primers spe-
cific for unflipped (wild-type) memory array were used to detect the wild-type
orientation of the spacer sequences (Table S6).
To characterize the function of integrase Int12 in B. thetaiotaomicron,
a pNBU2-based plasmid containing PBT3763-rpiL*C51RBS-Int12 was con-
structed and conjugated into B. thetaiotaomicron memory array strain
described above. For the recombinase response curve, an overnight culture
grown in TYG was diluted (1:100) into TYG or TYG supplemented with rham-
nose and grown for 8 hr at 37C. The final OD600 of each culture wasmeasured
using a Cary 50 UV-Vis spectrophotometer (Varion), and 500 ml of each cell cul-
ture was harvested by centrifugation, flash frozen, and stored at 80C until
DNA was extracted. For the recombinase time course assay, cells were grown
in TYG supplemented with 10 mM rhamnose for 8 hr at 37C, harvested peri-
odically, and stored as described above. DNA was isolated using the DNeasy
Blood and Tissue Kit (QIAGEN). Levels of integrase-mediated recombination
in vitro were quantified using qPCR with specific to the wild-type (unflipped)
(oAT836/837) or recombined (flipped) (oAT836/838) DNA at the target
sequence. For absolute quantitation, we used a standard curve generated
with purified DNA standards. Flipping ratio was calculated as (copies of flipped
DNA)/(copies of flipped DNA + copies of unflipped DNA).
Polymyxin B Susceptibility
Minimum inhibitory concentrations (MICs) were determined by broth microdi-
lution using TYG broth according to modified Clinical and Laboratory Stan-
dards Institute (CLSI) guidelines (Supplemental Experimental Procedures).
Fructose/Glucose Growth Assay
Overnight cultures were grown in TYG supplementedwith or without 100 mMof
IPTG. The following morning, samples were diluted 1:100 in MM supple-
mented with either 0.5% glucose or 0.5% fructose as the sole carbon source
and with or without 100 mM IPTG. Cultures were incubated anaerobically at
37C and 200 ml samples were withdrawn from the cultures every hour for
10 hr to monitor growth (OD600) in a BioTek Synergy H1 Hybrid Reader.
Animals
All animal study protocols were approved by the MIT Animal Care and
Use Committee. Specific-pathogen-free (SPF) female Swiss Webster miceCell Systems 1, 62–71, July 29, 2015 ª2015 Elsevier Inc. 69
(5-8 weeks) were purchased from Charles River and were housed and handled
in non-sterile conditions. Mice were fed irradiated mouse chow (PicoLab Ro-
dent Diet 20, LabDiet) and provided autoclaved or sterile filtered water for the
duration of the experiment. Prior to bacterial gavage, mice were adminis-
tered ciprofloxacin HCl (0.625 g/l), metronidazole (1 g/l) in sugar-sweetened
drinking water for 7 days and were subsequently treated with metronidazole
(100 mg/kg) by oral gavage every 24 hr and ciprofloxacin (0.625 g/l) dissolved
in drinking water for 3 days. Animals were transferred to a clean cage and pro-
vided fresh medicated water on the fifth day of the antibiotic regimen. Two
days after the cessation of antibiotic treatment, animals were inoculated
with engineered strains of B. thetaiotaomicron (5 3 108 CFU/mouse) by
oral gavage. Mice belonging to the same treatment group were cohoused
for the duration of the experiment. Fecal pellets were collected daily for lucif-
erase and qPCR analysis (described below).
Enumeration of B. thetaiotaomicron Strains In Vivo
Strains were enumerated by qPCR with strain-specific primers (Table S6)
targeting the NanoLuc (mmD662/663) or flipped (oAT836/838)/unflipped
(oAT836/837) memory array alleles in total fecal DNA. For absolute quantita-
tion, we used a standard curve generated with purified DNA standards.
Function of Inducible Promoters and CRISPRi In Vivo
After collection of stool 2 days post-bacterial gavage, mice were provided
drinking water supplemented with 25 mM IPTG, 5% arabinogalactan, or
kept on sterile water as controls. Normal drinking water was returned to ani-
mals 4 days post-bacterial gavage. For the arabinogalactan experiment, ani-
mals were transferred to a clean cage following removal of supplemented
drinking water. For the CRISPRi experiment, animals were transferred to a
clean cage 7 days post-bacterial gavage. Luciferase values were measured
daily and normalized to the cell density by determining the copy number of
NanoLuc by qPCR using primers mmD662/663.
Quantification of Memory Unit Recombination In Vivo
After collection of stool on Day 1, mice were provided with drinking water sup-
plemented with 0.5 M rhamnose or were maintained on sterile water as con-
trols. Mice were transferred to clean cages and returned to normal drinking
water 3 days post-bacterial gavage. Levels of integrase-mediated recombina-
tion in vivo were determined by analyzing fecal DNA (1 ml) by qPCR with
primers as described for the in vitro analysis. Flipping ratio was calculated
as (copies of flipped DNA)/(copies of flipped DNA + copies of unflipped DNA).
Data Analysis, Statistics, and Computational Methods
All data were analyzed using GraphPad Prism version 6.05 (GraphPad Soft-
ware, http://www.graphpad.com/). Error bars represent the SD of three exper-
iments carried out on different days. Fold repression was calculated by
dividing the luminescence of uninduced samples (RLU/CFU) by the lumines-
cence of samples treated with maximum inducer concentration. All response
curves were fit to a Hill function: Y = (BmaxX
n)/(Kn + Xn) + C, where X is the input,
Y is the output, Bmax is themaximum luminescence, n is the Hill coefficient, K is
the threshold, and C is baseline luminescence. RBS frequency logos were
generated for the region of the rpiL* RBS targeted by mutagenesis by
comparing the frequency of each nucleotide at each position within the sub-
population (strongest 7% of RBSs and weakest 7% of RBSs) to the frequency
of that nucleotide at that position in the full library.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and six tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cels.2015.06.001.
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